intellectual property
ERS Genomics CRISPR Patent Upheld in China
The Chinese patent office decision marks the latest ruling in a series of challenges to ERS Genomics' patent estate that have been filed around the world.
MilliporeSigma Licenses CRISPR IP to Huntington's Disease Research Nonprofit
The license will allow the nonprofit to edit cell lines and perform other research related to the discovery and development of therapies for Huntington's disease.
Japanese Patent Office Upholds ERS Genomics CRISPR Patent
The Japanese Patent Office's decision marks the second time the agency has ruled against challenges to the intellectual property's novelty and inventiveness.
Jumpcode Genomics NGS Library Enrichment Patent Revoked in Europe After Challenge by Takara Bio USA
The decision rings up another victory for Takara Bio in its patent spat with Jumpcode, which began in 2020 with Jumpcode challenging a Takara patent in Europe.
Court Grants Natera Injunction Against Invitae, ArcherDx in Use of Patented Products
The defendants are barred from using Personalized Cancer Monitoring products except for ongoing clinical trials, studies undergoing peer review, and quality control.